Patents Represented by Law Firm Millen & White
  • Patent number: 8349760
    Abstract: The invention concerns a homogeneous bed of particles of a catalyst, said catalyst comprising at least one amorphous matrix, at least one noble metal, at least one additional metal M and at least one halogen, and in which, for a catalyst particle, CPt is the local concentration of noble metal Pt; CM is the local concentration of additional metal M; CX is the local concentration of halogen; said catalyst being in the form of a homogeneous bed of particles, in which across the diameter of the particle, at least 70% of the values CPt/CM or CPt/CX differ from the mean local ratio by at most 30%, and in which the mole ratio M/Pt in the catalyst is in the range 1.8 to 6.
    Type: Grant
    Filed: June 5, 2003
    Date of Patent: January 8, 2013
    Assignee: IFP Energies nouvelles
    Inventors: Herve Cauffriez, Fabienne Le Peltier
  • Patent number: 8349182
    Abstract: The present invention concerns a fluid distributor in a multistage column, each plate P of the column being divided into a certain number of panels Pa, and each panel Pa being equipped with a distributor of the invention, said distributor comprising: a) a solid jet breaker located substantially in the axis of the outlet opening of the collecting baffle of the panel Pa; b) an intermediate perforated plate extending laterally beyond the jet breaker, with a degree of opening in the range 10% to 40%; c) a distribution plate extending over the entire panel Pa, and with a degree of opening in the range 5% to 20%.
    Type: Grant
    Filed: June 29, 2009
    Date of Patent: January 8, 2013
    Assignee: IFP
    Inventors: Frederic Augier, Denis Darmancier
  • Patent number: 8350465
    Abstract: The invention relates to phosphors having a garnet structure of the formula I (Ya,Lub,Sec,Tbd,The,Irf,Sbg)3?x (Al5?yMgy/2Siy/2)O12:Cex (I), where a+b+c+d+e+f+g+h+i=1 x=0.005 to 0.1 and y=0 to 4.0, and to a process for the preparation of these phosphors and to the use as conversion phosphors for conversion of the blue or near-UV emission from an LED.
    Type: Grant
    Filed: September 2, 2009
    Date of Patent: January 8, 2013
    Assignee: Merck Patent GmbH
    Inventors: Holger Winkler, Thomas Juestel, Julian Plewa
  • Patent number: 8350100
    Abstract: In a process for the preparation of ring compounds via a combinatorial synthesis, the reaction procedure is based on a Suzuki coupling; subsequent halo-demetallation and finally a further Suzuki coupling. The Suzuki couplings are each carried out with a boronic acid or a boronic acid ester. The reaction procedure uses provides novel ring compounds and uses novel synthesis units used for this purpose. The novel ring compounds are suitable for use as constituents in liquid-crystalline mixtures.
    Type: Grant
    Filed: February 16, 2012
    Date of Patent: January 8, 2013
    Assignee: Merck Patent GmbH
    Inventors: Detlef Pauluth, Peer Kirsch, Peter Baeuerle, Oliver Deeg
  • Patent number: 8349281
    Abstract: A process for sequestrating carbon emitted into the atmosphere in the form of CO2 comprises: a) a step for concentrating CO2 in the liquid phase; b) a step for electro-reduction in an aprotic medium to a compound in which the carbon changes to oxidation number +3 in the form of oxalic acid or formic acid; c) if appropriate, a step for re-extracting oxalic or formic acid in the aqueous phase; and d) a step for mineralization by reaction with a compound of an element M, resulting in a stable compound in which the atomic ratio C/M is about 2/1.
    Type: Grant
    Filed: December 10, 2004
    Date of Patent: January 8, 2013
    Assignee: IFP Energies nouvelles
    Inventors: Hervé Toulhoat, François Ropital, Sébastien Duval
  • Patent number: 8348902
    Abstract: An injection device adapted to the luer lock system and a syringe holder for making it is disclosed. The syringe holder for holding an inserted syringe, with a cap attached to the male luer at the tip, comprises a cylindrical barrel portion having an open distal end and an open proximal end, and a finger rest around the outer surface of the barrel portion at a position relatively closer to the proximal end, wherein a stopper means is provided at the inner surface of the barrel portion at the distal end thereof, the stopper means being designed to abut on the outer edge of the distal end of the syringe, and wherein a female-threaded sleeve extends forwardly from the distal end of the barrel portion, which is designed to surround the tip of the syringe and the cap, and wherein a proximal end cap is provided, at the proximal end of the barrel portion, which is designed to abut on the outer edge of the proximal end of the syringe, and has a bore to pass the piston rod through.
    Type: Grant
    Filed: October 26, 2006
    Date of Patent: January 8, 2013
    Assignee: JCR Pharmaceuticals Co., Ltd.
    Inventors: Kouichi Sugita, Hiroshi Matsumoto
  • Patent number: 8350071
    Abstract: The present invention describes a method of producing fatty acid alkyl esters and glycerin implementing, in a reaction section, a set of transesterification reactions between a vegetable or animal oil and an aliphatic monoalcohol, and using a heterogeneous solid catalyst, comprising: a) a stage of recontacting the effluent coming from the reaction section, and separated from the excess alcohol, with a glycerin phase, b) a stage of mixing said effluent with said glycerin phase, and c) a glycerin phase decantation stage. The supernatent ester phase obtained after decantation is then optionally sent to a coalescer, also allowing separation of the glycerin, then to a purification stage by adsorption on solids.
    Type: Grant
    Filed: June 9, 2008
    Date of Patent: January 8, 2013
    Assignee: IFP Energies nouvelles
    Inventors: Abdelhakim Koudil, Romain Rousset, Laurent Bournay, Franck Gaviot-Blanc
  • Patent number: 8347590
    Abstract: A cutter includes a male blade, a female blade, an advancement and retraction controller and a suction device. The male blade includes: a linear cutting portion linearly shaped with a predetermined thickness in a center part; a rounded cutting portion where a radius having a substantially arc shape in planar view is continuously formed from the linear cutting portion; and an end provided adjacent to the rounded cutting portion. The female blade has a fitting portion that is a hole conforming to the profile of the male blade in planar view and to which the male blade is fitted. On a lateral side of the female blade, an elongated hole for inserting a base film from one lateral side to the other lateral side is formed as an insertion portion.
    Type: Grant
    Filed: October 10, 2008
    Date of Patent: January 8, 2013
    Assignee: Idemitsu Unitech Co., Ltd.
    Inventor: Shuichi Goto
  • Patent number: 8349415
    Abstract: The present invention relates to a liquid-crystalline medium having high twist, to the use thereof for electro-optical purposes, and to displays containing this medium.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: January 8, 2013
    Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
    Inventors: Akihiro Kojima, Fumio Shimano
  • Patent number: 8349820
    Abstract: The invention relates to the use, optionally together with oral contraception, of estradiol valerate or 17?-estradiol in combination with 17?-cyanomethyl-17-?-hydroxyestra-4,9-dien-3-one (dienogest) in a multistage or single-stage combination preparation for oral therapy to maintain and/or increase feminine libido. The total number of daily dose units of the multistage combination and of a pharmaceutically harmless placebo or a single-stage combination and optionally the pharmaceutically harmless placebo-containing or placebo- and hormone-free daily dose units amounts to 28 daily dose units.
    Type: Grant
    Filed: October 17, 2007
    Date of Patent: January 8, 2013
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Susan Zeun, Holger Zimmermann, Susanne Parke
  • Patent number: 8344139
    Abstract: Crystal forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride, hydrates and solvates and processes for their preparation are provided. These crystal forms are either intermediates for the preparation of stable polymorphic form B or are suitable for solid formulations.
    Type: Grant
    Filed: May 10, 2010
    Date of Patent: January 1, 2013
    Assignee: Merck Eprova AG
    Inventors: Rudolf Moser, Viola Groehn, Thomas Egger, Fritz Blatter
  • Patent number: 8342209
    Abstract: In a fluid-transfer coupling device (5) that connects a plug (70) and a socket (10) to each other to communicate respective flow paths in the socket and the plug with each other, the plug includes, at least, an inner spacer (74) having an inner passage (78) formed to allow a passage of fluid, a plug collar (73) covering the outer circumferential surface of the inner spacer and a flange (75) formed on a proximal end of the plug to connect the plug to a conduit. The plug collar and the flange are made of metal. Consequently, even if the flow rate of the fluid is large, the plug can be firmly supported in the device. The inner spacer is made of a resinous material. In this connection, at least one portion of an outer circumferential portion of the plug may be formed of metal.
    Type: Grant
    Filed: December 5, 2006
    Date of Patent: January 1, 2013
    Assignee: Surpass Industry Co., Ltd.
    Inventor: Masahiro Hasunuma
  • Patent number: 8343963
    Abstract: The present invention relates to novel sulfamoyl-phenyl-ureido compounds having the formula (I) or a physiologically acceptable salt or derivative thereof which are suitable for the therapy of infections caused by protozoa and in particular uncomplicated or severe malaria caused by plasmodia.
    Type: Grant
    Filed: January 29, 2010
    Date of Patent: January 1, 2013
    Assignee: 4SC AG
    Inventor: Stefano Pegoraro
  • Patent number: 8344140
    Abstract: The present invention is directed towards new 18F-folate radiopharmaceuticals, wherein fluorine-18 is covalently linked through a triazole- or tetrazole linker to a folate or derivative thereof, a method of their preparation, as well as their use in diagnosis and monitoring of therapy of cancer and inflammatory and autoimmune diseases.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: January 1, 2013
    Assignee: Merck Eprova AG
    Inventors: Simon Mensah Ametamey, Rudolf Moser, Tobias Ludwig Ross, Thomas Leighton Mindt, Viola Groehn
  • Patent number: 8343412
    Abstract: The present invention relates to the sealing of inscriptions on plastics which have been produced by means of lasers on the plastic surface.
    Type: Grant
    Filed: January 25, 2011
    Date of Patent: January 1, 2013
    Assignee: Merck Patent GmbH
    Inventors: Sylke Klein, Tanja Lueckert (formerly Sandner)
  • Patent number: 8343855
    Abstract: The invention concerns a nanostructured device (100) comprising a substrate (101), an intermediate layer (102), a zone (103) consisting of multiple three-dimensional structured sites (104) made of semiconductor material, having chemical species (106) fixed to the surface of said three-dimensional nanostructured sites (104). The inventive device is useful for making a biochip and an electronic memory. The invention also concerns a method for forming an electronic memory.
    Type: Grant
    Filed: November 24, 2006
    Date of Patent: January 1, 2013
    Assignee: Commissariat A L'Energie Atomique
    Inventors: Pierre Mur, Cécile Oillic
  • Patent number: 8342232
    Abstract: A speed synchronization system in an aluminum alloy slab continuous casting and rolling line having a twin-belt casting machine and skin pass rolling machine which suitably controls a belt speed of the twin-belt casting machine and roll speed of the skin pass rolling machine so as to obtain a sound aluminum alloy continuously cast and rolled slab and a production facility and method of production of an aluminum alloy continuously cast and rolled slab using the same.
    Type: Grant
    Filed: September 25, 2006
    Date of Patent: January 1, 2013
    Assignee: Nippon Light Metal Company, Ltd.
    Inventors: Isao Shikine, Kazumi Tono
  • Patent number: 8338395
    Abstract: Described are methods for providing prolonged physiologically acceptable steady state serum testosterone levels in a patient deficient in endogenous testosterone levels, methods for male contraception and methods for treating a disease or symptom associated with deficient endogenous levels of testosterone in a man, by intramuscularly administering testosterone esters in a vehicle.
    Type: Grant
    Filed: February 24, 2009
    Date of Patent: December 25, 2012
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Doris Hubler, Sabine Fricke, Jan-Peter Ingwersen, Wilheim Kuhnz
  • Patent number: 8338507
    Abstract: The present invention relates to the use of phosphinic acids and/or phosphonic acids and salts thereof for wetting fluorine compounds, in particular fluoropolymers, to the use in coating solutions comprising fluorine compounds, and to polymerisation processes in which fluorine compounds are used and/or formed.
    Type: Grant
    Filed: November 22, 2008
    Date of Patent: December 25, 2012
    Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
    Inventors: Wolfgang Hierse, Nikolai (Mykola) Ignatyev
  • Patent number: RE43916
    Abstract: A combination product for oral contraception is disclosed comprising an estrogen selected from 2.0 to 6.0 mg of 17?-estradiol and 0.020 mg of ethinylestradiol; and a gestagen selected from 0.25 to 0.30 mg of drospirenone and 0.1 to 0.2 mg of cyproterone acetate, followed by 5 or 4 pill-free or sugar pill days.
    Type: Grant
    Filed: March 24, 2006
    Date of Patent: January 8, 2013
    Assignee: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Jurgen Spona, Bernd Dusterberg, Frank Ludicke